Additionally, increased seizure risk has been documented in patients with APP duplication (Cabrejo et al., 2006) and in Down syndrome (DS) individuals (carrying 3 copies of the APP gene) with dementia (Menéndez, 2005). This evidence concerns the gene APP and Down syndrome.